180 related articles for article (PubMed ID: 18198420)
1. Cerebral ischemia and Alzheimer's disease: the expression of amyloid-beta and apolipoprotein E in human hippocampus.
Qi JP; Wu H; Yang Y; Wang DD; Chen YX; Gu YH; Liu T
J Alzheimers Dis; 2007 Dec; 12(4):335-41. PubMed ID: 18198420
[TBL] [Abstract][Full Text] [Related]
2. The role of apolipoprotein E in the deposition of beta-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease.
Pluta R
Ann N Y Acad Sci; 2000 Apr; 903():324-34. PubMed ID: 10818522
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E deposition and astrogliosis are associated with maturation of beta-amyloid plaques in betaAPPswe transgenic mouse: Implications for the pathogenesis of Alzheimer's disease.
Terai K; Iwai A; Kawabata S; Sasamata M; Miyata K; Yamaguchi T
Brain Res; 2001 May; 900(1):48-56. PubMed ID: 11325345
[TBL] [Abstract][Full Text] [Related]
4. Intracerebroventricular injection of Aβ
Dai SJ; Zhang JY; Bao YT; Zhou XJ; Lin LN; Fu YB; Zhang YJ; Li CY; Yang YX
Pathol Res Pract; 2018 Oct; 214(10):1583-1595. PubMed ID: 30087036
[TBL] [Abstract][Full Text] [Related]
5. Tissue transglutaminase-catalysed cross-linking induces Apolipoprotein E multimers inhibiting Apolipoprotein E's protective effects towards amyloid-beta-induced toxicity.
de Jager M; Drukarch B; Hofstee M; Brevé J; Jongenelen CA; Bol JG; Wilhelmus MM
J Neurochem; 2015 Sep; 134(6):1116-28. PubMed ID: 26088696
[TBL] [Abstract][Full Text] [Related]
6. Interactions between Alzheimer's disease and cerebral ischemia--focus on inflammation.
Koistinaho M; Koistinaho J
Brain Res Brain Res Rev; 2005 Apr; 48(2):240-50. PubMed ID: 15850663
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E and beta-amyloid levels in the hippocampus and frontal cortex of Alzheimer's disease subjects are disease-related and apolipoprotein E genotype dependent.
Beffert U; Cohn JS; Petit-Turcotte C; Tremblay M; Aumont N; Ramassamy C; Davignon J; Poirier J
Brain Res; 1999 Oct; 843(1-2):87-94. PubMed ID: 10528114
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of Amyloid-β Protein Precursor, β-Secretase, Presenilin 1 and 2 Genes in the Rat Selectively Vulnerable CA1 Subfield of Hippocampus Following Transient Global Brain Ischemia.
Kocki J; Ułamek-Kozioł M; Bogucka-Kocka A; Januszewski S; Jabłoński M; Gil-Kulik P; Brzozowska J; Petniak A; Furmaga-Jabłońska W; Bogucki J; Czuczwar SJ; Pluta R
J Alzheimers Dis; 2015; 47(4):1047-56. PubMed ID: 26401782
[TBL] [Abstract][Full Text] [Related]
10. Ischemia-Reperfusion Programming of Alzheimer's Disease-Related Genes-A New Perspective on Brain Neurodegeneration after Cardiac Arrest.
Pluta R; Czuczwar SJ
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279289
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of Alzheimer's disease].
Alegre M; Noé E; Luquin MR
Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Tau Protein and Amyloid Protein Precursor Processing Genes in the CA3 Area of the Hippocampus in the Ischemic Model of Alzheimer's Disease in the Rat.
Pluta R; Ułamek-Kozioł M; Kocki J; Bogucki J; Januszewski S; Bogucka-Kocka A; Czuczwar SJ
Mol Neurobiol; 2020 Feb; 57(2):1281-1290. PubMed ID: 31713815
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
[TBL] [Abstract][Full Text] [Related]
14. Investigating APOE, APP-Aβ metabolism genes and Alzheimer's disease GWAS hits in brain small vessel ischemic disease.
Blumenau S; Foddis M; Müller S; Holtgrewe M; Bentele K; Berchtold D; Beule D; Dirnagl U; Sassi C
Sci Rep; 2020 Apr; 10(1):7103. PubMed ID: 32345996
[TBL] [Abstract][Full Text] [Related]
15. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.
Sadowski MJ; Pankiewicz J; Scholtzova H; Mehta PD; Prelli F; Quartermain D; Wisniewski T
Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18787-92. PubMed ID: 17116874
[TBL] [Abstract][Full Text] [Related]
16. Genetic associations between cathepsin D exon 2 C-->T polymorphism and Alzheimer's disease, and pathological correlations with genotype.
Davidson Y; Gibbons L; Pritchard A; Hardicre J; Wren J; Tian J; Shi J; Stopford C; Julien C; Thompson J; Payton A; Thaker U; Hayes AJ; Iwatsubo T; Pickering-Brown SM; Pendleton N; Horan MA; Burns A; Purandare N; Lendon CL; Neary D; Snowden JS; Mann DM
J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):515-7. PubMed ID: 16543533
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease.
Hartman RE; Laurer H; Longhi L; Bales KR; Paul SM; McIntosh TK; Holtzman DM
J Neurosci; 2002 Dec; 22(23):10083-7. PubMed ID: 12451108
[TBL] [Abstract][Full Text] [Related]
18. α-secretase cleaved amyloid precursor protein (APP) accumulates in cholinergic dystrophic neurites in normal, aged hippocampus.
Yoon SY; Choi JU; Cho MH; Yang KM; Ha H; Chung IJ; Cho GS; Kim DH
Neuropathol Appl Neurobiol; 2013 Dec; 39(7):800-16. PubMed ID: 23414335
[TBL] [Abstract][Full Text] [Related]
19. Changes in amyloid precursor protein and apolipoprotein E immunoreactivity following ischemic brain injury in rat with long-term survival: influence of idebenone treatment.
Pluta R; Barcikowska M; Debicki G; Ryba M; Januszewski S
Neurosci Lett; 1997 Aug; 232(2):95-8. PubMed ID: 9302095
[TBL] [Abstract][Full Text] [Related]
20. Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations.
Cataldo AM; Peterhoff CM; Troncoso JC; Gomez-Isla T; Hyman BT; Nixon RA
Am J Pathol; 2000 Jul; 157(1):277-86. PubMed ID: 10880397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
